Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM (2011) Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2011(5):CD1750
Andrejak M, Tribouilloy C (2013) Drug-induced valvular heart disease: an update. Arch Cardiovasc Dis 106:333–339
Choi J, Smitz J (2014) Luteinizing hormone and human chorionic gonadotropin: origins of difference. Mol Cell Endocrinol 383:203–213
Deutsches IVF-Register (2019) Jahrbuch 2018. J Reproduktionsmed Endokrinol 16:279–315
Fleseriu M (2011) Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review. Pituitary 14:184–193
van der Lely AJ, Biller BM, Brue T, Buchfelder M, Ghigo E, Gomez R, Hey-Hadavi J, Lundgren F, Rajicic N, Strasburger CJ, Webb SM, Koltowska-Häggström M (2013) Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. J Clin Endocrinol Metab 97:1589–1597
Melmed S (2006) Acromegaly. N Engl J Med 355:2558–2573
Melmed S (2019) Pathogenesis and diagnosis of growth hormone deficiency in adults. N Engl J Med 380:2551–2562
Mochtar MH, Danhof NA, Ayeleke RO, Van der Veen F, van Wely M (2017) Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. Cochrane Database Syst Rev 5:CD5070. https://doi.org/10.1002/14651858.CD005070.pub3
Moore WV, Nguyen HJ, Kletter GB, Miller BS, Rogers D, Ng D, Moore JA, Humphriss E, Cleland JL, Bright GM (2016) A randomized safety and efficacy study of somavaratan (VRS-317), a long-acting rhGH, in pediatric growth hormone deficiency. J Clin Endocrinol Metab 101:1091–1097
National Institute for Health and Care Excellence (2010) Human growth hormone (somatropin) for the treatment of growth failure in children. NICE technology appraisal guidance 188. http://www.nice.org.uk/guidance/ta188/resources/guidance-human-growth-hormone-somatropin-for-the-treatment-of-growth-failure-in-children-pdf
Pacchiarotti A, Sbracia M, Frega A, Selman H, Rinaldi L, Pacchiarotti A (2010) Urinary hMG (Meropur) versus recombinant FSH plus recombinant LH (Pergoveris) in IVF: a multicenter, prospective, randomized controlled trial. Fertil Steril 94:2467–2469
Perales-Puchalt A, Legro RS (2013) Ovulation induction in women with polycystic ovary syndrome. Steroids 78:767–772
Weiss NS, Kostova E, Nahuis M, Mol BWJ, van der Veen F, van Wely M (2019) Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Cochrane Database Syst Rev 1:CD10290. https://doi.org/10.1002/14651858.CD010290.pub3
van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Van der Veen F, Al-Inany HG (2012) Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review. Hum Reprod Update 18:111
Youssef MA, Abou-Setta AM, Lam WS (2016) Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database Syst Rev 4:CD3719. https://doi.org/10.1002/14651858.CD003719.pub4
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Der/die Herausgeber bzw. der/die Autor(en), exklusiv lizenziert durch Springer-Verlag GmbH, DE, ein Teil von Springer Nature
About this chapter
Cite this chapter
Schwabe, U. (2020). Hypophysen- und Hypothalamushormone. In: Schwabe, U., Ludwig, WD. (eds) Arzneiverordnungs-Report 2020. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-62168-4_28
Download citation
DOI: https://doi.org/10.1007/978-3-662-62168-4_28
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-62167-7
Online ISBN: 978-3-662-62168-4
eBook Packages: Medicine (German Language)